Dr. Anishka D'Souza
Claim this profileLos Angeles County-USC Medical Center
Studies Bladder Cancer
Studies Urethral Carcinoma
5 reported clinical trials
11 drugs studied
Area of expertise
1Bladder Cancer
Stage IV
Stage III
FGFR3 positive
2Urethral Carcinoma
Stage IV
Stage III
FGFR3 positive
Affiliated Hospitals
Clinical Trials Anishka D'Souza is currently running
Radium-223 + M3814 + Avelumab
for Prostate Cancer
This phase I/II trial studies the best dose of M3814 when given together with radium-223 dichloride or with radium-223 dichloride and avelumab and to see how well they work in treating patients with castrate-resistant prostate cancer that had spread to other places in the body (metastatic). M3814 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Radioactive drugs, such as radium-223 dichloride, may carry radiation directly to tumor cells and not harm normal cells. Immunotherapy with monoclonal antibodies, such as avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This study is being done to find out the better treatment between radium-223 dichloride alone, radium-223 dichloride in combination with M3814, or radium-223 dichloride in combination with both M3814 and avelumab, to lower the chance of prostate cancer growing or spreading in the bone, and if this approach is better or worse than the usual approach for advanced prostate cancer not responsive to hormonal therapy.
Recruiting1 award Phase 1 & 2
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
More about Anishka D'Souza
Clinical Trial Related6 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Anishka D'Souza has experience with
- Atezolizumab
- Eribulin Mesylate
- Cabozantinib S-malate
- Ipilimumab
- Nivolumab
- Avelumab
Breakdown of trials Anishka D'Souza has run
Bladder Cancer
Urethral Carcinoma
Kidney Cancer
Transitional Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anishka D'Souza specialize in?
Anishka D'Souza focuses on Bladder Cancer and Urethral Carcinoma. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Anishka D'Souza currently recruiting for clinical trials?
Yes, Anishka D'Souza is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Anishka D'Souza has studied deeply?
Yes, Anishka D'Souza has studied treatments such as Atezolizumab, Eribulin Mesylate, Cabozantinib S-malate.
What is the best way to schedule an appointment with Anishka D'Souza?
Apply for one of the trials that Anishka D'Souza is conducting.
What is the office address of Anishka D'Souza?
The office of Anishka D'Souza is located at: Los Angeles County-USC Medical Center, Los Angeles, California 90033 United States. This is the address for their practice at the Los Angeles County-USC Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.